Sulforaphane Represses Matrix‐Degrading Proteases and Protects Cartilage From Destruction In Vitro and In Vivo
Open Access
- 27 August 2013
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 65 (12) , 3130-3140
Abstract
Objective: Sulforaphane (SFN) has been reported to regulate signaling pathways relevant to chronic diseases. The aim of this study was to investigate the impact of SFN treatment on signaling pathways in chondrocytes and to determine whether sulforaphane could block cartilage destruction in osteoarthritis.Methods: Gene expression, histone acetylation, and signaling of the transcription factors NF‐E2–related factor 2 (Nrf2) and NF‐κB were examined in vitro. The bovine nasal cartilage explant model and the destabilization of the medial meniscus (DMM) model of osteoarthritis in the mouse were used to assess chondroprotection at the tissue and whole‐animal levels.Results: SFN inhibited cytokine‐induced metalloproteinase expression in primary human articular chondrocytes and in fibroblast‐like synovial cells. SFN acted independently of Nrf2 and histone deacetylase activity to regulate metalloproteinase expression in human articular chondrocytes but did mediate prolonged activation of JNK and p38 MAPK. SFN attenuated NF‐κB signaling at least through inhibition of DNA binding in human articular chondrocytes, with decreased expression of several NF‐κB–dependent genes. Compared with cytokines alone, SFN (10 μM) abrogated cytokine‐induced destruction of bovine nasal cartilage at both the proteoglycan and collagen breakdown levels. An SFN‐rich diet (3 μmoles/day SFN versus control chow) decreased the arthritis score in the DMM model of osteoarthritis in the mouse, with a concurrent block of early DMM‐induced gene expression changes.Conclusion: SFN inhibits the expression of key metalloproteinases implicated in osteoarthritis, independently of Nrf2, and blocks inflammation at the level of NF‐κB to protect against cartilage destruction in vitro and in vivo.Keywords
This publication has 53 references indexed in Scilit:
- Osteoarthritis: A disease of the joint as an organArthritis & Rheumatism, 2012
- Proteases involved in cartilage matrix degradation in osteoarthritisBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2012
- Sulforaphane destabilizes the androgen receptor in prostate cancer cells by inactivating histone deacetylase 6Proceedings of the National Academy of Sciences, 2009
- Modulation of histone deacetylase activity by dietary isothiocyanates and allyl sulfides: Studies with sulforaphane and garlic organosulfur compoundsEnvironmental and Molecular Mutagenesis, 2009
- Mitochondrial Dysregulation of Osteoarthritic Human Articular Chondrocytes Analyzed by ProteomicsMolecular & Cellular Proteomics, 2009
- Dietary histone deacetylase inhibitors: From cells to mice to manSeminars in Cancer Biology, 2007
- Molecular basis for chemoprevention by sulforaphane: a comprehensive reviewCellular and Molecular Life Sciences, 2007
- Oxygen and reactive oxygen species in cartilage degradation: friends or foes?Osteoarthritis and Cartilage, 2005
- Suppression of NF-κB and NF-κB-regulated gene expression by sulforaphane and PEITC through IκBα, IKK pathway in human prostate cancer PC-3 cellsOncogene, 2005
- Do antioxidant micronutrients protect against the development and progression of knee osteoarthritis?Arthritis & Rheumatism, 1996